| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |